Immunome Inc
NASDAQ:IMNM
Immunome Inc
NASDAQ:IMNM
Price:
21.83
USD
-3.15%
Market Closed
Market Cap:
$2.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Immunome Inc
NASDAQ:IMNM
|
US |
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
Vicom Ltd
SGX:WJP
|
SG |
|
U
|
Unilever PLC
F:UNVB
|
UK |
|
Berkeley Group Holdings PLC
LSE:BKG
|
UK |
|
C
|
Canada Goose Holdings Inc
F:1GC
|
CA |
|
K
|
Kistos PLC
LSE:KIST
|
UK |
|
C
|
Cbrain A/S
XBER:C6F
|
DK |
|
China Pacific Insurance Group Co Ltd
SSE:601601
|
CN |
|
Afya Ltd
NASDAQ:AFYA
|
BR |
|
Zurn Water Solutions Corp
NYSE:ZWS
|
US |
|
Y
|
Ypsomed Holding AG
XMUN:OWX
|
CH |
|
Faurecia SE
PAR:EO
|
FR |
|
Berry Corporation (Bry)
NASDAQ:BRY
|
US |
|
Iberdrola SA
MAD:IBE
|
ES |
|
PCB Bancorp
F:9UH
|
US |
|
Truist Financial Corp
NYSE:TFC
|
US |
Wall St Price Targets
IMNM Price Targets Summary
Immunome Inc
Immunome Inc
Wall Street analysts forecast IMNM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for IMNM is 35.96 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.
Lowest Forecast
Price Target
30.3
USD
39% Upside
Average Forecast
Price Target
35.96
USD
65% Upside
Highest Forecast
Price Target
42
USD
92% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMNM's stock price target?
Price Target
35.96
USD
35.96
USD
According to Wall Street analysts, the average 1-year price target for IMNM is 35.96 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.
What is the Revenue forecast for Immunome Inc?
Projected CAGR
95%
95%
The compound annual growth rate for Revenue over the next 8 years is 95%.
